Mike James, CEO, added. "Our first product in this revolutionary new line will help consumers address pain and avoid the risk of addiction and side effects associated with opiate-based and other pain drugs. We are excited to be at the forefront of holistic and natural medicine that leads to OTC opportunities in food, drug and mass retailers where we currently sell."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.